SCHEMBL9017494

SCHEMBL9017494

CCOC(=O)C(C)OS(=O)(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ATM Q13315 1/20 0.46
PIN1 Q13526 1/20 0.45
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
RAB9A P51151 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
TSHR P16473 2/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
HSD11B1 P28845 1/20 0.43
MMP8 P22894 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2325747 0.87 KMT2A (0.47) LMNAL3MBTL1NPC1SMN1; SMN2RAB9A
SCHEMBL7587366 0.87 KMT2A (0.47) LMNAL3MBTL1NPC1SMN1; SMN2RAB9A
SCHEMBL2081536 0.87 KMT2A (0.47) LMNAL3MBTL1NPC1SMN1; SMN2RAB9A
SCHEMBL10808641 0.85 TSHR (0.46) LMNAL3MBTL1NPC1SMN1; SMN2RAB9A
SCHEMBL15526544 0.84 KMT2A (0.45) LMNAATMPIN1NPC1SMN1; SMN2
SCHEMBL14258470 0.84 LMNA (0.43) LMNAL3MBTL1NPC1SMN1; SMN2RAB9A
SCHEMBL10012543 0.83 KMT2A (0.48) LMNAL3MBTL1ATMSMN1; SMN2ALDH1A1
SCHEMBL10012053 0.83 MEN1 (0.36) LMNAATMNPC1SMN1; SMN2RAB9A
SCHEMBL10011972 0.82 CYP3A4 (0.44) LMNAATMSMN1; SMN2RAB9AALDH1A1
SCHEMBL10011594 0.82 NPC1 (0.44) LMNAATMNPC1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8231468-A None JP disclosed
JP-H08231468-A LIQUID CRYSTAL COMPOUND UK GOVERNMENT 1996-09-10 JP disclosed
CN-1017242-B NEW QUIANZOLINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION FUJISAWA PHARMACEUTICAL CO (JP) 1992-07-01 CN disclosed
US-4883800-A DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-11-28 US disclosed
US-4734419-A Quinazoline derivatives, compositions thereof and their use in treating diabetic complications FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-03-29 US disclosed
CN-86106984-A New quinazoline derivant and preparation method thereof 1987-05-20 CN disclosed
EP-0218999-A2 New quinazoline derivatives, process for their production and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-04-22 EP disclosed